Pocket Program - CROI

Tuesday
March 5 Oral Sessions
Session 35 CROI 2013
e Tuesday, 4-6 pm; Ballroom 1-2
Session 35–Symposium
When Worlds Collide —Adolescents and HIV,
a symposium in memory of Edward Handelsman
Conveners:
Sabrina Bakeera-Kitaka, Makerere Univ,
Kampala, Uganda
Bill Kapogiannis, Natl Inst of Child Hlth
and Human Devt, NIH, Bethesda, MD, US
115
Ethical Issues in Adolescent HIV Prevention
Research
Sean Philpott
Ctr for Bioethics and Clinical Leadership, Union Grad Coll,
Schenectady, NY, US
116
What’s Fueling the HIV Epidemic in Gay/
Bisexual Male Adolescents and other Young
MSM?
Gary Harper
Univ of Michigan Sch of Publ Hlth, Ann Arbor, US
117
Preventing New HIV Infections among Young
African Women—Why Is It so Difficult?
Sinead Delany-Moretlwe
Univ of the Witwatersrand, Johannesburg, South Africa
118
Behavioral Challenges in Perinatally Infected
Youth
Claude Ann Mellins
New York State Psychiatric Inst and Columbia Univ, New York, US
Objectives: This session is designed for clinicians and
scientists interested in challenging issues pertaining
to adolescents and young adults living with HIV. It is assumed
that participants are familiar with basic epidemiology of HIV in
adolescents in high- and low-resource countries, and behavioral
and sociologic issues observed in youth with adult risk behaviors
and perinatally acquired HIV. At the completion of the session,
participants will be knowledgeable about ethical considerations
surrounding youth participation in vaccine and pre- and postexposure
prophylaxis trials, foundations and accelerators of the
epidemic in young MSM, impediments and successes in prevention
strategies in young women in Africa, and mental health outcomes in
youth who acquired HIV in infancy.
16 20th Conference on Retroviruses and Opportunistic Infections
e Tuesday, 4-6 pm; Hall B1
Session 36–Symposium
Opportunities and Threats to ART Success
Conveners:
Melanie Thompson, AIDS Res
Consortium, Atlanta, GA, US
Francois Venter, Wits Reproductive Hlth
and HIV Res Inst, Johannesburg, South
Africa
119
Political and Economic Threats to Sustainable
ARV Treatment
Jennifer Kates
Kaiser Family Fndn, Washington, DC, US
120
ART and Inflammation: Implications for the
Approach to Care in 2013
Sharon Lewin
Alfred Hosp, Monash Univ and Burnet Inst, Melbourne,
Australia
121
ARV Drug Resistance: Global Challenges
Raph Hamers
Academic Med Ctr of the Univ of Amsterdam;; Amsterdam Inst
for Global Hlth and Devt;; PharmAccess Fndn, Amsterdam,
The Netherlands
122
New HIV Drugs and Formulations: Effect on
Therapeutic Paradigms
Roy Gulick
Weill Cornell Med Coll, New York, NY, US
Objectives: This session is directed to clinicians
and scientists interested in ART including threats
to current progress, relationship to the chronic inflammatory state,
and the promise of new agents and formulations. It is assumed that
participants are familiar with the essentials of HIV pathogenesis and
ARV therapeutics. At the completion of the session, participants
will recognize the political and economic threats to sustaining the
progress made in the era of potent ART, understand the role that
artGG might play in the chronic immune activation state seen in
HIV + persons with controlled viremia, appreciate the current stateof-the-art
of ARV drug resistance, and gain knowledge of new ARV
drugs and formulations and the implications for changing paradigms
of therapy.